Mepidont (Mepivacaine Hydrochloride)

Mepivacaine works by reversibly blocking voltage‑gated sodium channels in neuronal membranes. This inhibition prevents the initiation and propagation of nerve impulses, thereby interrupting pain signal transmission in the targeted area. The effect is localized and wears off as the drug is metabolized.

The specific dose of Mepidont is determined by the prescribing clinician based on the procedure, patient age, weight, and medical condition. Dosing guidelines are provided in the product’s prescribing information, and the prescriber tailors the amount to achieve adequate anesthesia while minimizing risk.

Safety data for mepivacaine hydrochloride in pregnancy and lactation are limited, and the product is classified as pregnancy category unknown. Use during pregnancy or breastfeeding should only occur if the potential benefit justifies the potential risk, and it must be decided by the treating physician.

To place an order, submit an enquiry on the Mepidont product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mepidont (mepivacaine) is an amide‑type local anesthetic with a rapid onset and intermediate duration, similar to lidocaine but with slightly longer analgesia and less vasodilatory effect. Compared with bupivacaine, it has a shorter duration and lower cardiotoxicity, making it suitable for shorter procedures.

Store Mepidont at ambient temperature, preferably below 25 °C, in its original sealed container. Protect the vial from light, moisture and freezing. Inspect the solution for particulate matter or discoloration before use, and discard any product that appears compromised.

Mepidont is supplied as a sterile injection solution for local (dental) use. The clinician injects the solution directly into the target tissue or nerve area using a suitable syringe and needle. Administration techniques follow standard local anesthesia protocols, and the dose is adjusted to the clinical need.

Although rare, serious adverse reactions can include allergic anaphylaxis, cardiovascular toxicity such as arrhythmias or cardiac arrest, central nervous system effects like seizures, and prolonged numbness or respiratory depression. Immediate medical attention is required if any of these events occur.

Mepidont should be avoided in patients with known hypersensitivity to mepivacaine, other amide‑type local anesthetics, or any component of the formulation. Caution is also advised in individuals with severe cardiac disease, uncontrolled epilepsy, or significant hepatic impairment, and the decision to use it must be made by a qualified health professional.